Isan Chen
Founder at Mbrace Therapeutics, Inc.
Net worth: 3 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shane Burgess | M | - |
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 6 years |
| Mark Bray | M | 58 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 5 years |
| Sally Susman | F | 62 | 17 years | |
| Jake Simson | M | 38 | 4 years | |
| Ali Fawaz | M | - | 2 years | |
| Roger Sidhu | M | 48 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Robert Hudkins | M | 69 | 4 years | |
| Rehan Verjee | M | 43 | 3 years | |
| Siddarth Subramony | M | 37 | 4 years | |
| Melissa McCracken | M | 37 | 3 years | |
| Renata Pasqualini | M | - |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | - |
| Gilla Kaplan | M | 76 | 5 years | |
| Suzanne Johnson | F | 66 | 17 years | |
| Wadih Arap | M | - |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | - |
| Alan Fuhrman | M | 67 | 1 years | |
| Annaliesa Anderson | M | - | 17 years | |
| Markus Green | M | - | 18 years | |
| Philip Duong | M | 34 |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | - |
| Hiroomi Tada | M | - | 4 years | |
| Barbara Dalton | M | 69 | 17 years | |
| Piyush Patel | M | 59 | 3 years | |
| Ronald Swanson | M | - | 5 years | |
| Ryan Dietz | M | - |
Treadwell Therapeutics, Inc.
Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | 4 years |
| Racquel Bracken | F | 41 |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | 3 years |
| Robert More | M | 56 |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | - |
| Mikael Dolsten | M | 65 | 15 years | |
| Sarah Honig | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry McKinnell | M | 81 | 8 years | |
| Faheem Hasnain | M | 65 |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | 7 years |
| Richard Heyman | M | 66 |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | 4 years |
| Rodney Lappe | M | 69 | 15 years | |
| Perry Johnston | M | - | - | |
| Dennis Ausiello | M | 78 | 13 years | |
| Amy Schulman | F | 63 | 6 years | |
| Martin Godbout | M | - | 12 years | |
| Vickie Reed | F | 62 | 9 years | |
| William Ringo | M | 78 | 5 years | |
| David Shedlarz | M | 75 | 31 years | |
| Mark Gergen | M | 61 | 3 years | |
| John Mascotte | M | 84 | 4 years | |
| Marcy Graham | F | 57 | - | |
| Paul Fitzhenry | M | 63 | 4 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Neil Reisman | M | 62 | 1 years | |
| Alan Levin | M | 62 | 20 years | |
| Martin MacKay | M | 68 | 14 years | |
| Maya Martinez-Davis | F | 54 | 6 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Ranjeev Krishana | M | 50 | 7 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Daniel Faga | M | 44 | 1 years | |
| Robert Landry | M | 60 | 4 years | |
| Mace Rothenberg | M | 67 | 13 years | |
| Aaron Davis | M | 45 | 6 years | |
| Bruce Carter | M | 80 | 8 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Freda Lewis-Hall | M | 69 | 11 years | |
| Frances Fergusson | M | 79 | 9 years | |
| Peter Corr | M | 76 | 6 years | |
| Stephen W. Sanger | M | 78 | 9 years | |
| James Kilts | M | 76 | 13 years | |
| Temre Johnson | M | - | 5 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| Michael Grey | M | 71 | 7 years | |
| Reena Desai | F | - | - | |
| Julie Cherrington | M | 66 | 5 years | |
| Muriel Cottard | M | - | 4 years | |
| Carl Morris | M | 54 | 5 years | |
| William S. Korinek | M | - | 9 years | |
| John Chapman | M | 70 | 4 years | |
| Adrian Otte | M | - | 6 years | |
| Hong I. Wan | M | - | 5 years | |
| Mark J. Taisey | M | - | 5 years | |
| Sophia Randolph | M | 56 | 8 years | |
| Brian Krex | M | 57 | 9 years | |
| Lit-Fui Lau | M | 62 | 10 years | |
| John F. Fruhmann | M | - | - | |
| Hua Gong | M | 57 | 10 years | |
| Reina Benabou | M | 60 | 4 years | |
| Margaret Marshall | M | 67 | 8 years | |
| Tanya Clemons | M | - | - | |
| William C. Kennally | M | 67 | 5 years | |
| William J. Slichenmyer | M | 66 | 7 years | |
| Robert E. Grasty | M | 55 | - | |
| Lance Berman | M | 53 | 6 years | |
| Claus Egstrand | M | 63 | 3 years | |
| Jean-Michael Halfon | M | 72 | 21 years | |
| William Sigmund | M | - | 4 years | |
| Linda Armstrong | M | 61 | 6 years | |
| Martine George | M | 76 | 5 years | |
| Loretta Ucelli | F | - | - | |
| Karin Jooss | M | 59 | 7 years | |
| Nicholas Lee Gurreri | M | - | 4 years | |
| Eduardo Von Pervieux | M | - | 6 years | |
| Scott Cheshareck | M | - | 16 years | |
| Ronald Green | M | 63 | 12 years | |
| James H. Heym | M | - | 24 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Valerie Start | M | 64 | 3 years | |
| Michael Loechel | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Isan Chen
- Personal Network
